Glaxosmithkline LLC v. Teva Pharms. United States, Inc.

This document cites

• Federal Cases - Bayer Schering Pharma AG v. Lupin, Ltd.
• Federal Cases - United Therapeutics Corp. v. Sandoz, Inc.
• Federal Cases - AstraZeneca Pharms. LP v. Apotex Corp., 2011-1182
• Federal Cases - Metro-Goldwyn-Mayer Studios Inc. v. Grokster, Ltd.
• Federal Cases - Toshiba Corp. v. Imation Corp.



See all quotations

• Federal Cases - Astrazeneca Lp v. Apotex Inc.
• Federal Cases - 141 Ltd. P'ship And v. Microsoft Corp., 2009-1504.
• Federal Cases - Allergan, Inc. v. Alcon Laboratories, Inc.
• Federal Cases - Henderson v. Carlson
• Federal Cases - Ashcroft v. Iqbal
• Federal Cases - Organon, Inc. v. Teva Pharmaceuticals, Inc.
• Federal Cases - Fowler v. Upmc Shadyside
• Federal Cases - Phillips v. County of Allegheny
• Federal Cases - Takeda Pharm. USA, Inc. v. West-Ward Pharm. Corp.
• Federal Cases - Symantec Corp. v. Computer Associates Intern.
• Federal Cases - Andrx Pharmaceuticals Inc v. Biovail Corp
• Federal Cases - Warner-Lambert Co. v. Apotex Corp.
• Federal Cases - Aventis Pharma Deutschland v. Cobalt Pharmaceuts., CIV.A.03-10492-JLT.
• Federal Cases - Acorda Therapeutics, Inc. v. Apotex Inc.
• Federal Cases - National Presto Industries, Inc. v. West Bend Co., s. 94-1109
• US - Reference Stubs - Infringement of patent
• US - Reference Stubs - Presumption of validity; defenses
• US - Reference Stubs - Extension of patent term
• US - Reference Stubs - New drugs
• US - Reference Stubs - Jurisdiction, powers, and temporary assignment
• US - Reference Stubs - Claim for Relief Arising under 35 U.S.C. Section 271(e)(2) or 42 U.S.C. Section 262